Whitney Shoemaker
Gynecology · Ormond Beach, FLNPI 1750328514
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,567 of the $5,469 with a category attached, or 83.5%. It is spread thinly across 30 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,926 and has fallen 60.0% since, to $770 in 2024.
Across 216 payments — averaging $25.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$1K
- AbbVie$700
- Astellas Pharma US Inc$653
- Novo Nordisk$513
- Hologic Sales And Service, LLC$504
- Amgen$417
- plus $1K from 24 others
What the payments were for
- Travel & lodging$69713%
- Food & beverage$4,56783%
- Education$1903%
- Gifts$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 18 | $1,221 |
| AbbVie(2 entities) | 40 | $700 |
| Astellas Pharma US Inc | 27 | $653 |
| Novo Nordisk | 32 | $513 |
| Hologic Sales And Service, LLC | 19 | $504 |
| Amgen | 11 | $417 |
| Caldera Medical, Inc | 7 | $327 |
| Mayne Pharma Commercial LLC | 11 | $150 |
| Exeltis, USA Inc. | 6 | $113 |
| Lilly USA, LLC | 1 | $97 |
| Therapeuticsmd, Inc. | 5 | $87 |
| Minerva Surgical, Inc | 6 | $83 |
| Lupin Inc. | 4 | $71 |
| Coloplast | 1 | $70 |
| Laborie Medical Technologies Corp. | 3 | $51 |
| Boston Scientific | 3 | $48 |
| Daiichi Sankyo Inc. | 3 | $46 |
| Ironshore Pharmaceuticals Inc. | 2 | $39 |
| Meditrina | 2 | $39 |
| Millicent US Inc | 2 | $39 |
| Evofem Biosciences, Inc. | 2 | $31 |
| Myovant Sciences Inc. | 2 | $30 |
| Avion Pharmaceuticals | 2 | $26 |
| Nalpropion Pharmaceuticals LLC | 1 | $20 |
| BD | 1 | $18 |
| Aspira Women's Health Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Medtronic | 1 | $14 |
| Dysis Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bulkamid$782
- Axonics r-SNM System$677
- Desara$220
- MYOSURE TISSUE REMOVAL DEVICE$132
- Veozah$124
- Repatha$121
How this compares
$5,469 in reported general payments places this provider in the 85th percentile of 290 gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 59 | $42,520 |
| Estradiol | 200 | $11,849 |
| Mirabegron ErMirabegron | 11 | $3,431 |
| Clindamycin Phosphate | 35 | $2,221 |
| Clobetasol Propionate | 94 | $2,212 |
| ValacyclovirValacyclovir Hcl | 55 | $1,977 |
| Solifenacin Succinate | 17 | $1,143 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $1,091 |
| ProgesteroneProgesterone, Micronized | 32 | $1,010 |
| Ciprofloxacin Hcl | 84 | $622 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $511 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 28 | $437 |
| Megestrol Acetate | 21 | $409 |
| Fluconazole | 61 | $252 |
| Ibuprofen | 61 | $232 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $653 | $42,52059 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 290 gynecology providers in Florida.
Other gynecology in Ormond Beach
- Aileen CaceresKissimmee$406K
- Parveen VahoraNew Port Richey$327K
- James KondrupVenice$310K
- Andrea GallowayThe Villages$252K
- Jessica VaughtOrlando$129K
- Steven ChavoustieMiami$113K
- Marshall BovelskyMelbourne$52K
- Minda NeimarkFt Lauderdale$46K
- Meenakshi JainSt Petersburg$35K
- Michael SpragueWeston$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.